Clinical Trials on Covid19 in Japan
Total 71 results
-
Genova Inc.Tokyo Shinagawa HospitalRecruiting
-
Daiichi Sankyo Co., Ltd.Completed
-
Kitasato UniversityActive, not recruiting
-
University of JazanCompletedCovid19 | Pilates, Core StabilitySaudi Arabia
-
ModernaTX, Inc.CompletedCoronavirus Disease (COVID-19)Japan
-
Fujita Health UniversityElixirgen Therapeutics, Inc.Completed
-
TakedaWithdrawnSurvey of the Moderna COVID-19 Vaccine in People at High-Risk of Developing Severe COVID-19 SymptomsCoronavirus Disease (COVID-19)Japan
-
AstraZenecaActive, not recruitingCOVID-19, SARS-CoV-2Japan
-
Humanity & Health Medical Group LimitedTokyo University; Nihon University School of MedicineRecruiting
-
Rohto Pharmaceutical Co., Ltd.CompletedSARS-CoV-2 Infection( COVID-19 )Japan
-
TakedaCompleted
-
TakedaCompletedCoronavirus Disease (COVID-19)Japan
-
AstraZenecaCompleted
-
PfizerCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
PfizerActive, not recruitingCOVID-19 | SARS-CoV-2Japan
-
PfizerCompletedSARS-CoV-2 InfectionJapan
-
National Center for Global Health and Medicine,...Active, not recruitingCovid19 | Urine | Acute Respiratory Failure With Hypoxia | BiomarkerUnited States, Brazil, Denmark, Japan, Philippines
-
Bristol-Myers SquibbCompleted
-
Rohto Pharmaceutical Co., Ltd.CompletedSevere Acute Respiratory Syndrome Coronavirus 2Japan
-
BioNTech SEPfizerCompletedCOVID-19 | SARS-CoV-2 InfectionJapan
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompletedCOVID-19 Lower Respiratory InfectionJapan
-
AstraZenecaTerminatedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
TakedaCompletedPrevention of Infection Disease Caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)Japan
-
MedicagoMitsubishi Tanabe Pharma CorporationTerminated
-
AstraZenecaCompletedPrevention of Infectious Disease Caused by SARS-CoV-2Japan
-
AstraZenecaIqvia Pty LtdCompleted
-
AnGes, Inc.Japan Agency for Medical Research and DevelopmentCompleted
-
KK Women's and Children's HospitalNational University Hospital, Singapore; Ramathibodi Hospital; Universiti Kebangsaan... and other collaboratorsCompletedCOVID | Pediatric DisorderSingapore, Pakistan, Malaysia, India, China, Indonesia, Japan
-
AstraZenecaRecruiting
-
Ono Pharmaceutical Co. LtdCompletedSARS-CoV-2 Infection (COVID-19)Japan
-
University of MinnesotaNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedCOVID-19 | COVID | SARS-CoV-2 | SARS (Severe Acute Respiratory Syndrome)Spain, United States, Denmark, United Kingdom, Greece, Japan, Nigeria
-
Public Health Foundation of IndiaUniversity of Cape Town; Centre for Chronic Disease Control, India; World Heart...RecruitingCardiovascular Diseases | COVID-19Argentina, Bosnia and Herzegovina, Ghana, India, Iran, Islamic Republic of, Sudan, Colombia, Bangladesh, Japan, Kenya, Malaysia, Mexico, Nigeria, Pakistan, Portugal, South Africa, Zambia
-
U.S. Army Medical Research and Development CommandNo longer availableCoronavirus Disease 2019United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
AstraZenecaAcerta Pharma BVCompletedCOVID-19Italy, Turkey, Brazil, Japan, South Africa, Germany, Poland, Russian Federation, India, Peru, France, Argentina, Chile, Mexico
-
Children's Healthcare of AtlantaThe Hospital for Sick Children; Children's Hospital Medical Center, Cincinnati and other collaboratorsCompletedAcute Kidney Injury | COVIDUnited States, Canada, Spain, Israel, Japan, Serbia, United Kingdom
-
Merck Sharp & Dohme LLCCompletedCoronavirus Disease (COVID-19)Canada, France, Italy, Mexico, Philippines, Russian Federation, Spain, Ukraine, United Kingdom, United States, Argentina, Brazil, Chile, Colombia, Egypt, Germany, Guatemala, Israel, Japan, Poland, South Africa, Sweden, Taiwan
-
Hoffmann-La RocheAtea Pharmaceuticals, Inc.TerminatedCOVID-19Switzerland, Turkey, Denmark, Belgium, Japan, Mexico, Argentina, Brazil, Germany, Portugal, Romania, Ukraine
-
U.S. Army Medical Research and Development CommandNo longer availableTreatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)Severe Acute Respiratory Syndrome Coronavirus 2United States, Germany, Afghanistan, Djibouti, Guam, Iraq, Japan, Kuwait
-
UMC UtrechtNational University Hospital, Singapore; Berry Consultants; University of Pittsburgh... and other collaboratorsRecruitingCommunity-acquired Pneumonia, Influenza, COVID-19United Kingdom, United States, Canada, Australia, Netherlands, Croatia, Germany, Belgium, New Zealand, Ireland, Spain, Japan, Hungary, Colombia, India, Nepal, Pakistan, Portugal, Romania, Saudi Arabia
-
Alexion PharmaceuticalsTerminatedPneumonia, Viral | Acute Respiratory Distress Syndrome | Acute Lung Injury | COVID-19 Severe PneumoniaUnited States, Spain, United Kingdom, France, Japan